Back to Results
First PageMeta Content
Pharmaceutical sciences / Biotechnology / Bristol-Myers Squibb / Business / Sanofi / Pharmaceutical industry / Monoclonal antibodies


PRESS RELEASE Oncodesign Biotechnology and Bristol-Myers Squibb enter into Strategic Drug Discovery Collaboration  Collaboration is based on Oncodesign’s Nanocyclix® technology
Add to Reading List

Document Date: 2016-01-04 13:50:16


Open Document

File Size: 428,21 KB

Share Result on Facebook
UPDATE